Zokinvy Interactions
There are 529 drugs known to interact with Zokinvy (lonafarnib), along with 2 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 277 are major, 232 are moderate, and 20 are minor.
- View all 529 medications that may interact with Zokinvy
- View Zokinvy alcohol/food interactions (1)
- View Zokinvy disease interactions (2)
Most frequently checked interactions
View interaction reports for Zokinvy (lonafarnib) and the medicines listed below.
- Actemra (tocilizumab)
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Addyi (flibanserin)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- Alhemo (concizumab)
- Altuviiio (antihemophilic factor)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- Amondys 45 (casimersen)
- Amvuttra (vutrisiran)
- Andembry (garadacimab)
- apremilast
- Aridol (mannitol)
- atoltivimab / maftivimab / odesivimab
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- BabyBIG (botulism immune globulin)
- Bafiertam (monomethyl fumarate)
- baricitinib
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Brevital Sodium (methohexital)
- Nembutal (pentobarbital)
- Opsumit (macitentan)
Zokinvy alcohol/food interactions
There is 1 alcohol/food interaction with Zokinvy (lonafarnib).
Zokinvy disease interactions
There are 2 disease interactions with Zokinvy (lonafarnib) which include:
Report options
QR code containing a link to this page
More about Zokinvy (lonafarnib)
- Zokinvy consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
